Virtus ETF Advisers’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-967
Closed -$341K 656
2024
Q4
$341K Sell
967
-178
-16% -$62.8K 0.14% 213
2024
Q3
$410K Hold
1,145
0.19% 198
2024
Q2
$365K Sell
1,145
-355
-24% -$113K 0.18% 189
2024
Q1
$345K Buy
1,500
+216
+17% +$49.6K 0.18% 213
2023
Q4
$282K Sell
1,284
-58
-4% -$12.8K 0.18% 228
2023
Q3
$303K Sell
1,342
-177
-12% -$40K 0.18% 199
2023
Q2
$335K Buy
1,519
+406
+36% +$89.6K 0.2% 173
2023
Q1
$249K Buy
1,113
+20
+2% +$4.48K 0.14% 284
2022
Q4
$304K Buy
1,093
+16
+1% +$4.45K 0.16% 259
2022
Q3
$226K Buy
1,077
+14
+1% +$2.94K 0.09% 308
2022
Q2
$250K Sell
1,063
-855
-45% -$201K 0.09% 297
2022
Q1
$344K Hold
1,918
0.15% 161
2021
Q4
$414K Sell
1,918
-630
-25% -$136K 0.16% 136
2021
Q3
$470K Sell
2,548
-231
-8% -$42.6K 0.21% 147
2021
Q2
$499K Sell
2,779
-1,597
-36% -$287K 0.21% 152
2021
Q1
$732K Buy
4,376
+124
+3% +$20.7K 0.31% 102
2020
Q4
$645K Sell
4,252
-812
-16% -$123K 0.27% 96
2020
Q3
$511K Buy
5,064
+427
+9% +$43.1K 0.27% 132
2020
Q2
$561K Sell
4,637
-1,930
-29% -$233K 0.27% 131
2020
Q1
$623K Sell
6,567
-554
-8% -$52.6K 0.26% 147
2019
Q4
$627K Sell
7,121
-1,735
-20% -$153K 0.1% 180
2019
Q3
$706K Sell
8,856
-1,492
-14% -$119K 0.14% 162
2019
Q2
$808K Buy
10,348
+3,264
+46% +$255K 0.17% 183
2019
Q1
$831K Buy
7,084
+1,548
+28% +$182K 1.77% 15
2018
Q4
$603K Sell
5,536
-1,320
-19% -$144K 0.1% 44
2018
Q3
$877K Buy
6,856
+462
+7% +$59.1K 0.09% 58
2018
Q2
$723K Sell
6,394
-314
-5% -$35.5K 0.64% 91
2018
Q1
$754K Sell
6,708
-390
-5% -$43.8K 0.65% 85
2017
Q4
$1.05M Sell
7,098
-854
-11% -$126K 1.32% 10
2017
Q3
$932K Hold
7,952
0.13% 65
2017
Q2
$1.03M Buy
7,952
+454
+6% +$58.9K 0.15% 61
2017
Q1
$1.02M Buy
7,498
+721
+11% +$97.6K 0.18% 67
2016
Q4
$972K Buy
6,777
+973
+17% +$140K 0.29% 56
2016
Q3
$685K Buy
5,804
+731
+14% +$86.3K 0.33% 52
2016
Q2
$537K Buy
5,073
+1,404
+38% +$149K 0.4% 45
2016
Q1
$409K Buy
+3,669
New +$409K 0.56% 48